Bone marrow stromal cell antigen 2 (BST2), expressed by several human cancer cell lines, has been identified as the physiological ligand of ILT7 that inhibits the transcription and secretion of I-IFN and other pro-inflammatory cytokines by pDCs [68]. Here, LILRA4 is linked to cancer.